Skip to content
New patients Save $50 on your hormone panel: $69, normally $119 No insurance · Provider review included · Free priority shipping Check my eligibility
Log in Find my treatment
Juan Montes

Author

Juan Montes

Clinical content writer and reviewer

Juan Montes writes and reviews PrescribedRX's clinical content, covering testosterone replacement therapy, men's sexual health, weight management and hair loss.

  • 173 articles
  • 2011 in healthcare since
  • English & Spanish languages

About Juan

He trained as a Professional Nurse at the Colombian Red Cross in Cali, Colombia, and has worked in healthcare since 2011, roughly six of those years in direct emergency and critical care nursing. He served as Head Nurse in Emergency Services at Piloto Jamundí Hospital, as an Emergency Nurse with Emergencias Médicas S.A. in Buenos Aires, and as Head Nurse across the emergency room and intensive care unit at San Francisco Clinic, where his work covered critical protocols, ventilation and medication management, and patient triage.

More recently he has worked in clinical documentation in the United States, as a Medical Scribe supporting oncology and hematology specialists at Arizona Southwest Cancer Care. He holds current ACLS certification from the American Heart Association and HIPAA Professional certification, and works in both English and Spanish as a medical translator and interpreter.

His role in your care

Juan's clinical training and licensure are international rather than United States-based. He writes PrescribedRX's educational content; he does not prescribe and he is not your clinician. Every prescription is written by a clinician licensed in your state through Telegra MD.

How our articles are written

Articles cite their sources, such as FDA labels, peer-reviewed studies and clinical guidelines, and show the date they were last updated. They explain treatments; they do not replace a visit with a licensed clinician.

Articles by Juan

Two columns comparing a manufactured product, made at scale and reviewed before it is sold, against a compounded preparation, made for one patient on a prescription and not reviewed before it is dispensed Weight loss · 4 min read Compounded Tirzepatide: What It Is A smiling mature businesswoman looking at the camera in an office Weight loss · 3 min read Tirzepatide Cost: What We Charge, Published Up Front Comparison of the FDA label doses for Egrifta SV and WR, the 2 mg phase 3 trial dose, and no studied dose for fat loss or bodybuilding Longevity · 4 min read Tesamorelin Dosage: The Label, the Trials and the Gap Chart showing visceral adipose tissue falling 18 percent by week 26 on tesamorelin then rebounding after treatment stops Longevity · 5 min read Tesamorelin: What the FDA Label Actually Says Side by side comparison showing neither BPC-157 nor TB-500 has a human interventional study for injury Longevity · 4 min read BPC-157 vs TB-500: What the Evidence Actually Says Comparison of synthetic Epitalon as four amino acids against Epithalamin as a crude pineal extract, with the 266 person study attributed to Epithalamin Longevity · 5 min read Epitalon: What Was Actually Studied Three randomised controlled trials totalling 181 patients, annotated as published in Russian without independent replication Longevity · 5 min read Semax: The One Peptide Here With Human Trials, and Their Limits Bar of 43 segments representing thymosin beta-4 with residues 17 to 23 highlighted as the TB-500 fragment Longevity · 6 min read TB-500 and Thymosin Beta-4: Not the Same Molecule An empty chart axis with no data plotted, representing the absence of published human MOTS-c dosing Longevity · 6 min read MOTS-c Dosage: What Is Actually Published Grid of 36 squares, 35 marked preclinical and one marked human, from the 2025 BPC-157 systematic review Longevity · 7 min read BPC-157: What the Research Actually Shows Chart showing four preclinical KPV studies and zero human studies Longevity · 7 min read KPV Peptide: What the Research Actually Shows Diagram: peptides removed from FDA Category 2 in April 2026 did not move onto the 503A Bulks List, which remains empty of them Longevity · 5 min read Peptides and US Compounding Law: Current Status Tracker

Ready to find out what fits?

Answer a few questions and a licensed provider takes it from there. Every price is on the page, and nothing is prescribed unless it is appropriate for you.

Check my eligibility